Lifeboat Foundation

Experts at Adelaide’s Flinders University have made an Alzheimer’s breakthrough that may result in world’s first dementia vaccine. Developed by Australian and US scientists, this vaccine may not only prevent but also reverse early stages of Alzheimer’s, the most common form of dementia.

The Alzheimer’s vaccine may be tested on humans within the next two to three years after being bankrolled by the US Government. Scientists from Flinders University and America’s Institute of Molecular Medicine and University of California developed the vaccine by targeting proteins in the brain that block neurons.

The formula targets tau proteins and abnormal beta-amyloid that cause Alzheimer’s. The scientists are confident that the vaccine would eventually be used as preventative vaccine. According to Flinders University medicine professor Nikolai Petrovsky, the proteins must be removed from the brain as Alzheimer’s, and dementia sufferers have lots of these broken down proteins inside.

Continue reading “Alzheimer’s breakthrough: Vaccine developed” »

The SV trend.

Employees at San Francisco startup Nootrobox don’t eat on Tuesdays.

The weekly fast isn’t an extreme money-saving move by a scrappy, bootstrapping company. Instead, Nootrobox team members swear withholding food for 36 hours — they stop eating Monday night — improves their workplace focus and concentration.

Continue reading “Brain ‘hacking’: Entrepreneurs turn to fasting and ‘smart drugs’” »

Is it time for rehab for junk food junkies?

Apparently, all the burgers and smoothies you’re consuming cause your brain to forget to stop eating even when you’re full.

Can you relate to midnight cravings and the feeling of perpetual hunger? Do you resort to grabbing fast food on the fly or eating out of a tub of ice cream while you’re bored around the house?

Continue reading “Eating Sugar And Fatty Foods Is As Bad As Doing Drugs” »

Alfred G. Knudson Jr., a medical researcher who helped decode a mystery of cancer — using genetics, mathematics and intuition to explain how and why certain forms of the disease attack — died July 10 at his home in Philadelphia. He was 93.

His death was announced by the Fox Chase Cancer Center in Philadelphia, where Dr. Knudson had served as president, scientific director and in other capacities since joining the institution in 1976. He had heart ailments and dementia, said his wife, Anna Meadows, a pediatric oncologist.

Dr. Knudson was among the most renowned researchers in his field, with honors including a 1998 Lasker Award, commonly known as the American Nobel, and a 2004 Kyoto Prize recognizing him for a discovery that “opened a new horizon in modern cancer genetics and played a pivotal role in the major developments” in cancer research.

Continue reading “Alfred G. Knudson Jr., geneticist who decoded a mystery of cancer, dies at 93” »

The Allen Brain Observatory is open for business, revealing what’s running through the mind of a mouse as it sees patterns of light and dark, pictures of butterflies and tigers – or even the opening scene of Orson Welles’ 1958 classic film, “Touch of Evil.”

The online repository of 30 trillion bytes’ worth of brain-cell readings represents the latest scientific offering from the Allen Institute for Brain Science, funded by Microsoft co-founder Paul Allen. It follows through on a $300 million pledge that Allen made more than four years ago.

Continue reading “Allen Brain Observatory peers into the minds of mice as they watch movies” »

Good; and as I had hope it could be done for many years.

Recalling a favorite song could be enough to unlock computers one day. All you’ll need is a tiny earbud to register the electro-brainwaves, researchers say.

Ray Kurzweil is a celebrity technologist, well known both for his work as an inventor and for his relatively accurate predictions of technological change. Among his predictions is that of an imminent biotech revolution, which may enable people to restore and maintain healthy life for much longer periods of time than those humans have enjoyed historically. In the meantime, Ray says he takes 250 dietary supplements each day, in addition to receiving half a dozen intravenous therapies each week.

“Although my program may seem extreme, it is actually conservative – and optimal (based on my current knowledge). [My doctor] and I have extensively researched each of the several hundred therapies that I use for safety and efficacy. I stay away from ideas that are unproven or appear to be risky (the use of human-growth hormone, for example).” – Ray Kurzweil in The Singularity Is Near (pages 211–212)

Some of Ray’s dietary supplements are nootropics, intended to maintain and improve brain health. He lists them in his book, Transcend (pages 15 and 22). I’ve compared the nootropics he recommends to reviews on Examine.com, an independent and unbiased encyclopedia on supplementation and nutrition that is not affiliated in any way with any supplement company. Below is a table that summarizes what I found, followed by some observations.

Continue reading “Ray Kurzweil’s Nootropic Dietary Supplement Stack” »

(NaturalNews) Earlier this month, Juno Therapeutics, a pioneer in the field of treating cancer using genetically engineered cells, had to halt the development of its lead treatment after the death of three leukemia patients enrolled in the study.

The Seattle-based biotech company reported that the deaths of all three patients, who were in their 20s, were linked to swelling in the brain. The swelling occurred after the company added a second chemotherapy drug to the treatment procedure.

The news of the patient deaths is a big blow for the biotech startup that is developing a new experimental therapy known as chimeric antigen receptor T-cell (or CART) immunotherapy. The setback will likely delay the company’s aim of introducing it to the market by 2017, Juno executives said in a conference.

Continue reading “FDA study using genetically engineered cells to treat cancer kills three people” »

More update on controlling drones with BMI.

Using wireless interface, operators control multiple drones by thinking of various tasks.

Continue reading “System controls robots with the brain” »